` 2269 (Meiji Holdings Co Ltd) vs Nikkei 225 Comparison - Alpha Spread

2269
vs
Nikkei 225

Over the past 12 months, has outperformed Nikkei 225, delivering a return of -3% compared to the Nikkei 225's 7% drop.

Stocks Performance
2269 vs Nikkei 225

Loading
2269
Nikkei 225
Add Stock

Performance Gap
2269 vs Nikkei 225

Loading
2269
Nikkei 225
Difference

Performance By Year
2269 vs Nikkei 225

Loading
2269
Nikkei 225
Add Stock

Competitors Performance
Meiji Holdings Co Ltd vs Peers

Nikkei 225
2269
NESN
MDLZ
BN
KHC
Add Stock

Meiji Holdings Co Ltd
Glance View

Market Cap
897.7B JPY
Industry
Food Products

Meiji Holdings Co., Ltd. has long been a staple in the world of Japanese consumer goods, specifically in the food and pharmaceutical sectors. Established in 2009 as a result of merging Meiji Seika Kaisha, Ltd. and Meiji Dairies Corporation, the company stands as a testament to the power of strategic consolidation, leveraging over a century of expertise from its predecessors. The company's robust product portfolio spans a diverse array of offerings, including dairy products like yogurts and milk, confectioneries like chocolate and candy, as well as nutrition bars and supplements. This triumvirate of product lines allows Meiji Holdings to position itself in both the everyday consumer market and in specialized health-centric industries, exploiting economies of scale and extensive distribution networks that reach far beyond the Japanese archipelago. In the pharmaceutical arena, Meiji Holdings operates under its subsidiary, Meiji Seika Pharma, focusing predominantly on antibacterial drugs, central nervous system treatments, and veterinary products. By integrating research and development with a comprehensive marketing strategy, the company capitalizes on global health trends and regional disease challenges, expanding in markets that emphasize health and dietary improvements. Financially, Meiji Holdings generates revenue by producing goods that tap into both traditional consumer desires and modern nutritional trends. It makes money by introducing high-margin pharmaceutical innovations alongside its well-established consumer brands, thus benefiting from both everyday sales and solutions aimed at pressing global health needs. Together, these strategic components make Meiji Holdings an agile player in a competitive global market, combining heritage with innovation.

Intrinsic Value
4 114.94 JPY
Undervaluation 19%
Intrinsic Value
Price
Back to Top